Successful integrase inhibitor-based highly active antiretroviral therapy for a multidrug-class-resistant HIV type 1 group O-infected patient in Cameroon.
about
Non-M variants of human immunodeficiency virus type 1.Patients infected by tuberculosis and human immunodeficiency virus facing their disease, their reactions to disease diagnosis and its implication about their families and communities, in Burkina Faso: a mixed focus group and cross sectional studyHIV-1 group O infection in Cameroon from 2006 to 2013: Prevalence, genetic diversity, evolution and public health challenges.HIV-1 non-group M phenotypic susceptibility to integrase strand transfer inhibitors.HIV-1 Group O Genotypes and Phenotypes: Relationship to Fitness and Susceptibility to Antiretroviral Drugs.Genetic diversity in HIV-1 subtype C LTR from Brazil and Mozambique generates new transcription factor-binding sites.
P2860
Successful integrase inhibitor-based highly active antiretroviral therapy for a multidrug-class-resistant HIV type 1 group O-infected patient in Cameroon.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Successful integrase inhibitor ...... -infected patient in Cameroon.
@en
Successful integrase inhibitor ...... -infected patient in Cameroon.
@nl
type
label
Successful integrase inhibitor ...... -infected patient in Cameroon.
@en
Successful integrase inhibitor ...... -infected patient in Cameroon.
@nl
prefLabel
Successful integrase inhibitor ...... -infected patient in Cameroon.
@en
Successful integrase inhibitor ...... -infected patient in Cameroon.
@nl
P50
P356
P1476
Successful integrase inhibitor ...... -infected patient in Cameroon.
@en
P2093
Avelin F Aghokeng
Eitel Mpoudi-Ngole
P356
10.1089/AID.2012.0196
P577
2012-09-11T00:00:00Z